Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Julphar
McKesson
Fish and Richardson
Teva
Cerilliant
Citi
Cantor Fitzgerald
Moodys
Federal Trade Commission

Generated: January 19, 2018

DrugPatentWatch Database Preview

Pharmacia And Upjohn Company Profile

« Back to Dashboard

Summary for Pharmacia And Upjohn
International Patents:211
US Patents:9
Tradenames:110
Ingredients:85
NDAs:136
Drug Master File Entries: 41

Drugs and US Patents for Pharmacia And Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn DEPO-TESTOSTERONE testosterone cypionate INJECTABLE;INJECTION 085635-003 Approved Prior to Jan 1, 1982 AO RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER clindamycin phosphate INJECTABLE;INJECTION 050639-002 Aug 30, 1989 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn NEO-MEDROL ACETATE methylprednisolone acetate; neomycin sulfate CREAM;TOPICAL 060611-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn PANMYCIN tetracycline hydrochloride TABLET;ORAL 061705-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CLEOCIN T clindamycin phosphate GEL;TOPICAL 050615-001 Jan 7, 1987 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CLEOCIN clindamycin phosphate CREAM;VAGINAL 050680-002 Mar 2, 1998 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn MEDROL methylprednisolone TABLET;ORAL 011153-003 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn TOLINASE tolazamide TABLET;ORAL 015500-005 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 AT RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn MEDROL methylprednisolone TABLET;ORAL 011153-002 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Pharmacia And Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn GLYNASE glyburide TABLET;ORAL 020051-004 Sep 24, 1993 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn XANAX alprazolam TABLET;ORAL 018276-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn ZYVOX linezolid TABLET;ORAL 021130-002 Apr 18, 2000 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn PSORCON diflorasone diacetate OINTMENT;TOPICAL 019260-001 Aug 28, 1985 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-008 Jan 27, 1998 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-004 Aug 24, 1995 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn XANAX alprazolam TABLET;ORAL 018276-004 Nov 27, 1985 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn GLYNASE glyburide TABLET;ORAL 020051-001 Mar 4, 1992 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for PHARMACIA AND UPJOHN drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 2 mg/mL, 100 mL bag ➤ Subscribe 12/29/2009
➤ Subscribe Injection 2 mg/mL, 300 mL bag ➤ Subscribe 9/1/2009
➤ Subscribe Oral Suspension 100 mg/5 mL ➤ Subscribe 8/3/2009
➤ Subscribe Extended-release Capsules 2 mg and 4 mg ➤ Subscribe 7/30/2007
➤ Subscribe Tablets 600 mg ➤ Subscribe 12/21/2005
➤ Subscribe Tablets 1 g ➤ Subscribe 8/23/2005

Non-Orange Book US Patents for Pharmacia And Upjohn

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,780,279 Method of selection of proteolytic cleavage sites by directed evolution and phagemid display ➤ Subscribe
5,955,346 Variants of human prolactin and human placeatal lactogen ➤ Subscribe
6,428,954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants ➤ Subscribe
5,534,617 Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 ➤ Subscribe
8,637,646 Growth hormone variants ➤ Subscribe
6,451,561 Growth hormone variants ➤ Subscribe
5,834,598 Human growth hormone variants ➤ Subscribe
6,040,136 Enrichment method for variant proteins with altered binding properties ➤ Subscribe
6,022,711 Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1 ➤ Subscribe
6,004,931 Method for inhibiting growth hormone action ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Pharmacia And Upjohn Drugs

Supplementary Protection Certificates for Pharmacia And Upjohn Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/2004 Austria ➤ Subscribe PRODUCT NAME: DROSPIRENON IN KOMBINATION MIT ESTRADIOL; NAT. REGISTRATION NO/DATE: 1-25178, 1-25179 20031127; FIRST REGISTRATION: NL RVG 27505 20021211
C029/2005 Ireland ➤ Subscribe SPC029/2005: 20061023, EXPIRES: 20171112
00617 Netherlands ➤ Subscribe PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
C0043 France ➤ Subscribe PRODUCT NAME: PEGVISOMANT; REGISTRATION NO/DATE: EU/1/02/240/001-003 20021113
C/GB09/026 United Kingdom ➤ Subscribe PRODUCT NAME: ESTRADIOL AND COMBINATIONS OF ESTRADIOL AND DIENOGEST, PREFERABLY ESTRADIOL VALERATE AND COMBINATIONS OF ESTRADIOL VALERATE AND DIENOGEST; REGISTERED: BE BE 327792 20081103; UK PL 00010/0576-0001 20081208
C0128 France ➤ Subscribe PRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718
C0037 Belgium ➤ Subscribe PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
C/GB00/027 United Kingdom ➤ Subscribe PRODUCT NAME: INSULIN ASPART AND PROTAMINE (NOVOMIX 30); REGISTERED: CH 55414 01 20000623; CH 55415 02 20000623; CH 55416 02 20000623; UK EU/1/00/142/001-008 20000801
00C/027 Belgium ➤ Subscribe PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
C0046 Belgium ➤ Subscribe PRODUCT NAME: DOXORUBICIN HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/96/011/001 19960624
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Chubb
McKinsey
Queensland Health
Chinese Patent Office
Accenture
Daiichi Sankyo
Express Scripts
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot